---
layout: minimal-medicine
title: Idarubicin
---

# Idarubicin
### Generic Name
Idarubicin

### Usage

Idarubicin is a potent chemotherapy drug classified as an anthracycline antineoplastic agent.  Its primary use is in the treatment of acute myeloid leukemia (AML), a serious type of blood cancer. It's typically used in combination with other chemotherapy medications as part of a treatment regimen, rather than as a standalone therapy.  Idarubicin is also sometimes used in the treatment of acute promyelocytic leukemia (APL), a subtype of AML.  The specific combination of drugs and the dosage will depend on factors such as the type and stage of leukemia, the patient's overall health, and other relevant medical history.

### Dosage

Idarubicin dosage is highly individualized and depends on several factors, including the patient's age, weight, overall health, and the specific treatment protocol being followed.  Dosages are usually calculated based on body surface area (m²).  It's crucial to emphasize that the information below is for general understanding and should *never* replace the instructions provided by a healthcare professional.  

**Adult Dosage:**  Dosages vary considerably depending on whether it is used for induction, consolidation, or in combination with other agents in AML or APL.  For instance, in AML induction, a common intravenous (IV) dose is 12 mg/m²/day for 3 days, often combined with cytarabine.  In APL, dosage and duration vary depending on the specific treatment protocol (e.g., LPA 2005, APML4).  Oral administration is also possible, but the doses and regimens differ significantly from IV administration and are determined by the treating physician.

**Pediatric Dosage:**  Pediatric dosages are also determined by body surface area and are significantly different from adult doses.  Regimens frequently involve combinations with other drugs,  with doses varying depending on the specific treatment protocol (e.g., IdaDCTER regimen for AML).

**Dosage Adjustments:**  Dosage adjustments are often necessary based on factors such as hepatic (liver) and renal (kidney) function.  Reduced doses are typically prescribed for patients with impaired liver or kidney function.  Monitoring of blood counts (CBC) is essential to adjust the dosage based on the severity of bone marrow suppression.

### Side Effects

Idarubicin, like many chemotherapy drugs, can cause a range of side effects.  The severity and frequency of these side effects vary from person to person.

**Common Side Effects:**

* Nausea and vomiting
* Diarrhea
* Mouth sores (stomatitis)
* Hair loss (alopecia)
* Skin rash
* Fatigue
* Bone marrow suppression (leading to anemia, low white blood cell count, and low platelet count)
* Liver function abnormalities (increased bilirubin and liver enzymes)
* Darkening of urine


**Serious but Less Common Side Effects:**

* Severe heart problems (cardiomyopathy, heart failure)
* Severe infections (due to bone marrow suppression)
* Bleeding problems (due to low platelet count)
* Peripheral neuropathy (nerve damage)
* Second cancers (long-term risk)

**Important Note:** If you experience any concerning side effects, especially those listed as serious, contact your healthcare provider immediately.

### How it Works

Idarubicin is an anthracycline antibiotic that works by interfering with the processes of DNA and RNA synthesis within cancer cells. It does this in two main ways:

1. **Intercalation:** The drug inserts itself between the base pairs of DNA, disrupting the DNA structure and preventing it from replicating properly.
2. **Topoisomerase II Inhibition:** Idarubicin inhibits topoisomerase II, an enzyme essential for DNA replication and repair.  By inhibiting this enzyme, idarubicin further prevents cancer cell division and promotes their death.  This targeted action against rapidly dividing cancer cells makes it effective in treating leukemia.

### Precautions

* **Hypersensitivity:** Idarubicin is contraindicated in patients with known hypersensitivity to idarubicin, other anthracyclines, or any components of the formulation.
* **Cardiotoxicity:** Idarubicin can cause significant heart damage, particularly in patients with pre-existing heart conditions or those who have received prior anthracycline therapy. Cardiac function monitoring is essential.
* **Bone Marrow Suppression:**  This is a major risk, leading to increased susceptibility to infections and bleeding.  Regular blood tests are needed to monitor this.
* **Hepatic and Renal Impairment:** Dosage adjustments are necessary for patients with impaired liver or kidney function.
* **Pregnancy and Breastfeeding:** Idarubicin is categorized as pregnancy category D, meaning it poses a risk to a developing fetus.  Breastfeeding is not recommended during treatment.
* **Drug Interactions:** Idarubicin can interact with other medications, so it's crucial to inform your healthcare provider about all medications, supplements, and herbal remedies you are taking.
* **Extravasation:** If the drug leaks out of the vein during intravenous administration (extravasation), it can cause severe tissue damage.  Careful intravenous administration is crucial.


### FAQs

* **Q: How is idarubicin administered?** A:  Idarubicin is typically administered intravenously (IV) but can be given orally in certain situations.  The specific route and method will be determined by your healthcare provider.

* **Q: How long will I need to take idarubicin?** A: The duration of treatment varies greatly depending on the type and stage of leukemia, your response to treatment, and other individual factors. Your doctor will determine the length of your treatment course.

* **Q: How should idarubicin be stored?** A:  Storage instructions will vary depending on the formulation (e.g., intravenous solution vs. oral capsules). Always follow the specific storage instructions provided with your medication.

* **Q: What should I do if I miss a dose?** A: Contact your healthcare provider immediately if you miss a dose.  Never double the dose to make up for a missed dose.

* **Q: Are there long-term effects of idarubicin?** A:  Long-term side effects are possible, including heart damage and increased risk of other cancers.  Regular follow-up care with your doctor is essential.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Always consult with your healthcare provider before starting or changing any treatment plan.  They can provide personalized guidance based on your specific health needs and medical history.
